Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H28FN3O3.CH4O3S |
Molecular Weight | 497.58 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.COC1=C(OCCCN2CCN(CC2)C3=C(F)C=CC=C3)C=CC(NC(C)=O)=C1
InChI
InChIKey=SEUMNMFHYBUUEX-UHFFFAOYSA-N
InChI=1S/C22H28FN3O3.CH4O3S/c1-17(27)24-18-8-9-21(22(16-18)28-2)29-15-5-10-25-11-13-26(14-12-25)20-7-4-3-6-19(20)23;1-5(2,3)4/h3-4,6-9,16H,5,10-15H2,1-2H3,(H,24,27);1H3,(H,2,3,4)
Molecular Formula | C22H28FN3O3 |
Molecular Weight | 401.4744 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | CH4O3S |
Molecular Weight | 96.106 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Mafoprazine is a phenylpiperazine derivative exerting postsynaptic dopamine D2 receptor blocking activity and alpha-adrenergic activity (alpha 1 receptor blocking activity and alpha 2 receptor stimulating activity). In animal models, mafoprazine demonstrated antipsychotic, aggression-inhibiting and cataleptogenic actions.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P61169 Gene ID: 24318.0 Gene Symbol: Drd2 Target Organism: Rattus norvegicus (Rat) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
10.7 nM [Ki] | ||
Target ID: CHEMBL1907610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
12.6 nM [Ki] | ||
Target ID: CHEMBL2093864 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
101.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Neurochemical study of mafoprazine, a new phenylpiperazine derivative. | 1988 May |
|
A behavioral pharmacological study of mafoprazine, a new phenylpiperazine derivative. | 1988 Oct |
|
Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system. | 1989 Jul |
|
Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands. | 1991 Oct 4 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:10:20 GMT 2023
by
admin
on
Sat Dec 16 19:10:20 GMT 2023
|
Record UNII |
XK8XMW4J8Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C18361
Created by
admin on Sat Dec 16 19:10:20 GMT 2023 , Edited by admin on Sat Dec 16 19:10:20 GMT 2023
|
PRIMARY | |||
|
84374-39-0
Created by
admin on Sat Dec 16 19:10:20 GMT 2023 , Edited by admin on Sat Dec 16 19:10:20 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
6918020
Created by
admin on Sat Dec 16 19:10:20 GMT 2023 , Edited by admin on Sat Dec 16 19:10:20 GMT 2023
|
PRIMARY | |||
|
80428-31-5
Created by
admin on Sat Dec 16 19:10:20 GMT 2023 , Edited by admin on Sat Dec 16 19:10:20 GMT 2023
|
PRIMARY | |||
|
XK8XMW4J8Z
Created by
admin on Sat Dec 16 19:10:20 GMT 2023 , Edited by admin on Sat Dec 16 19:10:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|